Sulforaphane Modulates Cell Migration and Expression of βCatenin and Epithelial Mesenchymal Transition Markers in Breast Cancer Cells
Open Access
- 10 June 2020
- journal article
- research article
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 49 (1) , 77-85
Abstract
Background: We aimed to assess the effect of sulforaphane (SFN) on breast cancer cell migration and also its effect on the expression of epithelial mesenchymal transition (EMT) markers and β-catenin. Methods: This study was performed in Shahroud University of Medical Sciences, Shahroud, Iran from 2017- 2018. In this experimental study, MDA-MB-231 cells were treated with different concentrations of SFN (5, 10, 20, 30 and 40 μM) at different time points of 24, 48, and 72 h. The control group was untreated cells. The inhibitory effects of different concentrations of SFN on cell migration at different time points were evaluated using scratch assay. Moreover, apoptosis was assessed by using flow cytometric analysis. The expression of βcatenin and EMT markers of ZEB1, fibronectin, and claudin-1 were determined by real-time PCR. Western blotting analysis of β-catenin was applied to determine its changes after SFN treatment. Results: SFN markedly inhibited the migration of cells at concentrations of 10, 20, 30, and 40µM after 24, 48, and 72 h. At relatively, high concentrations (30, 40µM), SFN induced apoptosis. Moreover, SFN reduced the gene expression of ZEB1, fibronectin, and claudin-1 after 72 h. The expression of β-catenin revealed a timedependent decrease at the concentration of 40 µM SFN. Conclusion: Downregulation of EMT markers and β-catenin showed accordance with the inhibition of migration. SFN could be a promising drug candidate to reduce metastasis in breast cancer.Keywords
This publication has 39 references indexed in Scilit:
- Claudin 1 expression in basal-like breast cancer is related to patient ageBMC Cancer, 2013
- Sulforaphane inhibits growth of phenotypically different breast cancer cellsEuropean Journal of Nutrition, 2013
- MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasisJournal of Clinical Investigation, 2013
- Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapyCancer, 2012
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- The Claudin family and its role in cancer and metastasisFrontiers in Bioscience-Landmark, 2011
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene DiscoveryPLOS ONE, 2009
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motilityOncogene, 2006
- Claudin-1 regulates cellular transformation and metastatic behavior in colon cancerJournal of Clinical Investigation, 2005